Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • The Pharma 50

Trump accuses FDA of delaying Pfizer’s COVID-19 vaccine announcement 

By Brian Buntz | November 13, 2020

Donald Trump

President Donald Trump [Image courtesy of White House]

In the aftermath of Pfizer’s (NYSE: PFE) announcement that its COVID-19 vaccine promises to be 90% effective, President Trump is faulting the FDA for its role allegedly delaying the announcement until after Election Day. The President has pointed to the episode as evidence for a ‘medical deep state,” according to the Washington Post.

Already, HHS Secretary Alex Azar had reportedly discussed the prospect of removing Dr. Stephen Hahn as FDA commissioner.

Now, Trump has requested that Azar “get to the bottom” why the Pfizer announcement came after Election Day, according to a Washington Post article citing an anonymous source. After the Pfizer announcement, Trump reportedly called Hahn “screaming at him,” according to the newspaper.

In a recent coronavirus task force meeting, Hahn said that the timing of the Pfizer announcement was based on the company’s independent decisions alone.

Pfizer CEO Albert Bourla echoed that sentiment in a recent CNN interview, stating that the announcement’s timing was based on scientific rather than political considerations.

Azar, however, argued differently, suggesting that FDA deliberately caused a delay in Pfizer’s announcement.

The timing of Pfizer’s is coincidental, according to the Annenberg Public Policy Center FactCheck.org

Tensions between the White House and the FDA had been building for months, according to Politico.


Filed Under: clinical trials, Drug Discovery, Drug Discovery and Development
Tagged With: coronavirus, covid-19, COVID-19 vaccine, FDA, HHS, Pfizer, vaccine
 

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Related Articles Read More >

Lab facility
Massachusetts is competing for ARPA-H biomedical research center
Blockchain
Startup vies to get blockchain adoption in pharma off the ground
Black Diamond Therapeutics
Black Diamond analysis highlights 22 new oncogenic HER2 driver mutations
NIH National Institutes of Health
NIH licenses COVID-19 research technologies to WHO initiative

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • The Pharma 50